🇺🇸 FDA
Patent

US 6051387

Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies

expired A61KA61K2039/505A61K47/6851

Quick answer

US patent 6051387 (Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies) held by The Regents of the University of California expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K47/6851, A61K47/6913, A61K51/1045